Cargando…

Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency

BACKGROUND: The burden of proteinases from inflammatory cells in the lung of subjects with type Pi ZZ of alpha-1-antitrypsin deficiency is higher than in those without the deficiency. Cross-sectional studies have shown increased levels of biomarkers of extracellular matrix degradation in vivo. Longi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stolk, Jan, Veldhuisen, Barbara, Annovazzi, Laura, Zanone, Chiara, Versteeg, Elly M, van Kuppevelt, Toine H, Nieuwenhuizen, Willem, Iadarola, Paolo, Luisetti, Maurizio
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1159172/ https://www.ncbi.nlm.nih.gov/pubmed/15927063 http://dx.doi.org/10.1186/1465-9921-6-47

Ejemplares similares

Correction: Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency
por: Stolk, Jan, et al.
Publicado: (2006)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
por: Viglio, Simona, et al.
Publicado: (2021)

The parallel lives of alpha(1)-antitrypsin deficiency and pulmonary alveolar proteinosis
por: Trapnell, Bruce C, et al.
Publicado: (2013)

The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency
por: Pini, Laura, et al.
Publicado: (2014)

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
por: Viglio, Simona, et al.
Publicado: (2020)

SP-A binds alpha(1)-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase
por: Gorrini, Marina, et al.
Publicado: (2005)

Basilar Predominant Emphysema: Thinking beyond Alpha-1-Antitrypsin Deficiency
por: Yeung, Ho-Man, et al.
Publicado: (2022)

CELA1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency
por: Devine, Andrew J., et al.
Publicado: (2023)

Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
por: Chotirmall, Sanjay H, et al.
Publicado: (2015)

The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients
por: Schouten, Iris G. M., et al.
Publicado: (2021)

Identifying Alpha-1 Antitrypsin Deficiency Based on Computed Tomography Evidence of Emphysema
por: Miskoff, Jeffrey A, et al.
Publicado: (2019)

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency
por: Perotin, Jeanne Marie, et al.
Publicado: (2018)

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences
por: Fregonese, Laura, et al.
Publicado: (2008)

Discovery of an Inhibitor of Z-Alpha1 Antitrypsin Polymerization
por: Berthelier, Valerie, et al.
Publicado: (2015)

Intrahepatic heteropolymerization of M and Z alpha-1-antitrypsin
por: Laffranchi, Mattia, et al.
Publicado: (2020)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
por: Buck, Emanuel, et al.
Publicado: (2022)

Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema
por: Blanco, Ignacio, et al.
Publicado: (2011)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
por: Veith, Martina, et al.
Publicado: (2020)

Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency
por: Everaerts, Stephanie, et al.
Publicado: (2023)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
por: Sark, Annelot D., et al.
Publicado: (2022)

Alpha(1)-antitrypsin deficiency: current perspective on research, diagnosis, and management
por: Stolk, Jan, et al.
Publicado: (2006)

How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?
por: Ferrarotti, Ilaria, et al.
Publicado: (2015)

Circulating alpha1-antitrypsin in the general population: Determinants and association with lung function
por: Senn, Oliver, et al.
Publicado: (2008)

Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; Methodological advances
por: Parr, David G, et al.
Publicado: (2008)

Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD)
por: Ataya, Ali
Publicado: (2020)

Role of Drosophila EDEMs in the degradation of the alpha-1-antitrypsin Z variant
por: JANG, BO-YUN, et al.
Publicado: (2015)

Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency
por: O'Brien, Michael E, et al.
Publicado: (2020)

Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease
por: Serban, K.A., et al.
Publicado: (2022)

Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature
por: Parr, David G, et al.
Publicado: (2017)

Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report
por: Denden, Sabri, et al.
Publicado: (2009)

Polymerization of misfolded Z alpha-1 antitrypsin protein lowers CX3CR1 expression in human PBMCs
por: Tumpara, Srinu, et al.
Publicado: (2021)

Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values
por: Stoel, Berend C., et al.
Publicado: (2019)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
por: Rahaghi, Franck F., et al.
Publicado: (2017)

A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha-1 antitrypsin deficiency and non-alpha-1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma
por: Theegarten, Dirk, et al.
Publicado: (2004)

In Vivo Electroporation-Mediated, Intrahepatic Alpha1 Antitrypsin Gene Transfer Reduces Pulmonary Emphysema in Pallid Mice
por: Sutter, Marco A., et al.
Publicado: (2020)

Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema
por: Takeda, Katsuyuki, et al.
Publicado: (2021)

Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice
por: Park, Sangmi S., et al.
Publicado: (2023)

Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
por: Mayer, Annyce S, et al.
Publicado: (2006)

Prevalence of PI*Z and PI*S alleles of alpha-1-antitrypsin deficiency in Finland
por: Häggblom, Jan, et al.
Publicado: (2015)

Heterozygosity of the Alpha 1‐Antitrypsin Pi*Z Allele and Risk of Liver Disease
por: Hakim, Aaron, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ij98eq1q3svl2d938mqc7nikg